NDC 0002-8233
Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen
Insulin Lispro
Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen is a Subcutaneous Injection, Suspension in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Insulin Lispro.
Product ID | 0002-8233_14062960-5954-4bb0-b1b3-66322c8eec8a |
NDC | 0002-8233 |
Product Type | Human Prescription Drug |
Proprietary Name | Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen |
Generic Name | Insulin Lispro |
Dosage Form | Injection, Suspension |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2020-02-12 |
Marketing Category | BLA / NDA AUTHORIZED GENERIC |
Application Number | BLA021017 |
Labeler Name | Eli Lilly and Company |
Substance Name | INSULIN LISPRO |
Active Ingredient Strength | 100 [iU]/mL |
Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |